Press Releases

Abbott announced  that an independent panel of experts convened by the U.S. Food and Drug Administration (FDA) voted 9 to 0, with one abstention, that the benefits of Abbott's Absorb fully bioresorbable drug eluting coronary stent outweigh the risks....

Novartis announced that the United States FDA approved Afinitor® tablets for the treatment of adult patients with progressive, well-differentiated, nonfunctional neuroendocrine tumors of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic. Afinitor...

TYG oncology, a UK biotechnology company specializing in hormone neutralization therapy for gastrointestinal cancers, and OncoQR ML GmbH, an Austrian biotechnology company specializing in developing therapeutic vaccines against oncological and infectious disease targets using the S-TIR™ technology platform, have...

In the summer of 2015, an event drew record-breaking single-day crowds of over 170,000 professionals to Shanghai solely for the healthcare sector. It was a mega trade event combining the top medical and pharmaceutical events in China, the Health...

CPhI China, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo, will be held on 21 – 23rd June 2016 in Shanghai New International Expo Center....

Guaranteed drug quality and promoted drug reliability are foundation for the success of all pharmaceuticals. Cleanliness is considered to be an area of the greatest change in hardware transformation in the "harshest" GMP certification. The important task, pharmaceuticals are...

BioPh China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo, will be held on 21 – 23 June 2016 at Hall E2 in Shanghai...